Digestive Enzyme Supplementation in Gastrointestinal Diseases

被引:84
作者
Ianiro, Gianluca [1 ]
Pecere, Silvia [1 ]
Giorgio, Valentina [2 ]
Gasbarrini, Antonio [1 ]
Cammarota, Giovanni [1 ]
机构
[1] Catholic Univ, Sch Med & Surg, A Gemelli Hosp Rome, Dept Med Sci,Div Internal Med,Gastroenterol & Liv, Largo A Gemelli 8, IT-00168 Rome, Italy
[2] Catholic Univ, Sch Med & Surg, A Gemelli Hosp Rome, Div Pediat, IT-00168 Rome, Italy
关键词
Bile acids; celiac disease; enzyme supplementation; gastrointestinal disease; lactose intolerance; pancreatic insufficiency; EXOCRINE PANCREATIC INSUFFICIENCY; INTESTINAL BACTERIAL OVERGROWTH; SWEET ACIDOPHILUS MILK; LACTIC-ACID BACTERIA; CYSTIC-FIBROSIS; LACTOSE-MALABSORPTION; URSODEOXYCHOLIC ACID; CELIAC-DISEASE; REPLACEMENT THERAPY; BETA-GALACTOSIDASE;
D O I
10.2174/138920021702160114150137
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Digestive enzymes are able to break down proteins and carbohydrates and lipids, and their supplementation may play a role in the management of digestive disorders, from lactose intolerance to cystic fibrosis. To date, several formulations of digestive enzymes are available on the market, being different each other in terms of enzyme type, source and origin, and dosage. Methods: This review, performed through a non-systematic search of the available literature, will provide an overview of the current knowledge of digestive enzyme supplementation in gastrointestinal disorders, discussion of the use of pancreatic enzymes, lactase (beta-galactosidase) and conjugated bile acids, and also exploring the future perspective of digestive enzyme supplementation. Results: Currently, the animal-derived enzymes represent an established standard of care, however the growing study of plant-based and microbe-derived enzymes offers great promise in the advancement of digestive enzyme therapy. Conclusion: New frontiers of enzyme replacement are being evaluated also in the treatment of diseases not specifically related to enzyme deficiency, whereas the combination of different enzymes might constitute an intriguing therapeutic option in the future.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 60 条
[1]   Yogurt and gut function [J].
Adolfsson, O ;
Meydani, SN ;
Russell, RM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (02) :245-256
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]  
[Anonymous], PRESCR REF GEN PRACT
[4]   EFFICACY OF LACTASE-TREATED MILK FOR LACTOSE-INTOLERANT PEDIATRIC-PATIENTS [J].
BILLER, JA ;
KING, S ;
ROSENTHAL, A ;
GRAND, RJ .
JOURNAL OF PEDIATRICS, 1987, 111 (01) :91-94
[5]   International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients [J].
Borowitz, Drucy ;
Stevens, Christopher ;
Brettman, Lee R. ;
Campion, Marilyn ;
Chatfield, Barbara ;
Cipolli, Marco .
JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (06) :443-452
[6]  
Bourlioux P, 1988, World Rev Nutr Diet, V56, P217
[7]   Hydrogen breath test with glucose in exocrine pancreatic insufficiency [J].
Casellas, F ;
Guarner, L ;
Vaquero, E ;
Antolín, M ;
de Gracia, X ;
Malagelada, JR .
PANCREAS, 1998, 16 (04) :481-486
[8]  
Colombo C, 1996, HEPATOLOGY, V23, P1484
[9]  
Damerla Venugopal, 2008, J Support Oncol, V6, P393
[10]   ENZYME REPLACEMENT FOR LACTOSE-MALABSORPTION USING A BETA-D-GALACTOSIDASE [J].
DIPALMA, JA ;
COLLINS, MS .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1989, 11 (03) :290-293